Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome- Acute Kidney Injury (HRS-AKI)

Released On
June 28, 2022

Expires On
June 28, 2023

Media Type
Internet

Completion Time
60 minutes

Specialty
Critical Care, Emergency Medicine, Gastroenterology, Hepatology, Nephrology, Primary Care

Topic(s)
Cirrhosis/Liver disease, Kidney disease

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

 

This activity is supported by an educational grant from Mallinckrodt Pharmaceuticals.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This educational activity is directed toward health care providers serving patients with cirrhosis, including hepatologists, gastroenterologists, nephrologists, critical care specialists, physician assistants, and nurses. Other health care professionals are also invited to participate.

Activity Overview

This Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) is a video-based program in which 2 experts use a case-based approach to discuss the treatment and management of HRS-AKI. In this activity, the faculty focus on the current and emerging therapeutic strategies for the diagnosis and management of HRS-AKI and review investigational therapies. This engaging format is designed to help clinicians identify best practices in the diagnosis and management of HRS-AKI and to improve outcomes for their patients with this disease.

Learning Objectives

Upon completion of this activity, you should be better prepared to:

  • Define the criteria used to diagnose hepatorenal syndrome of acute kidney injury.
  • Summarize the pathophysiology of hepatorenal syndrome of acute kidney injury.
  • Implement evidence-based treatments for hepatorenal syndrome of acute kidney injury.

 

Faculty

FACULTY_NAME

Elizabeth Verna, MD, MSc

Frank Cardile Associate Professor of Medicine
Director of Hepatology Research
Division of Digestive and Liver Diseases
Department of Medicine
Columbia University Irving Medical Center
New York, NY

FACULTY_NAME

Arun B. Jesudian, MD

Associate Professor of Clinical Medicine
Director of Inpatient Liver Services
Weill Cornell Medicine
Division of Gastroenterology and Hepatology
New York, NY

 

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Elizabeth Verna, MD, MSc
  • Grant/Research Support: Salix Pharmaceuticals.
Arun B. Jesudian, MD
  • Consultant: Salix Pharmaceuticals, Dynavax Technologies
  • Speaker’s Bureau: Salix Pharmaceuticals

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.